Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
Wei-Li Xia(Zhengzhou University), Hai-Liang Li(Zhengzhou University), Yuan Guo(University of Leeds), Zhen Li(Tongji Hospital), Shi‐Jun Xu(Chengdu University of Traditional Chinese Medicine), Xiao-Hui Zhao(Zhengzhou University), Weijun Fan(Sun Yat-sen University), Hongtao Hu(Wuhan University), Guangshao Cao(Henan University)
Cited by 15
Related Papers
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR
|Nature Structural & Molecular Biology|2004|607
Microalgal-bacterial consortia: From interspecies interactions to biotechnological applications
|Renewable and Sustainable Energy Reviews|2019|440
Cancer drug delivery in the nano era: An overview and perspectives
|Oncology Reports|2017|399
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295
Enhancement of aerobic granulation and nutrient removal by an algal–bacterial consortium in a lab-scale photobioreactor
|Chemical Engineering Journal|2017|289